• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:张伊凡,胡馨一,盛亮.蓝萼香茶菜提取物通过抑制IRE1α-TRAF2-ASK1-JNK1通路缓解小鼠非酒精性脂肪性肝炎[J].药学研究,2026,45(1):1-8,46[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2927次   下载 888次 本文二维码信息
码上扫一扫!
蓝萼香茶菜提取物通过抑制IRE1α-TRAF2-ASK1-JNK1通路缓解小鼠非酒精性脂肪性肝炎
张伊凡,胡馨一,盛亮
字体:加大+|默认|缩小-
(南京医科大学,江苏 南京 211166)
摘要:
目的 探讨蓝萼香茶菜提取物(RJE)对非酒精性脂肪性肝炎(NASH)的治疗作用及机制。方法 采用胆碱缺乏、L-氨基酸定义的高脂肪饮食(CDAHFD)诱导C57BL/6小鼠的NASH病变,给与RJE(0.2和0.4 mL•10 g-1)治疗2周;检测血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)水平;苏木精-伊红 (H&E) 染色、油红O染色和天狼星红染色评估肝脏病理;检测肝脏甘油三酯(TAG)、羟脯氨酸水平等;RT-qPCR法检测肝脏肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、单核细胞趋化蛋白-1(MCP-1)、CC趋化因子配体5(CCL5)、转化生长因子-β(TGF-β)、α-平滑肌肌动蛋白(α-SMA)和Ⅰ型胶原a1(Collagen1a1) 的mRNA水平;Western blotting分析α-SMA蛋白表达;通过网络药理学数据库获取RJE靶点与NASH靶点交集,进行GO功能和KEGG通路富集分析,预测潜在治疗靶点;体外实验以棕榈酸(PA,0.33 mmol•L-1)和脂多糖(LPS,1 μg•mL-1)处理AML-12细胞建立NASH模型,RJE(5 μg•mL-1)干预20 h后检测细胞活力,RT-qPCR法分析炎症因子表达(TNF-α、IL-1β、MCP-1、CCL5),以及Western blotting检测IRE1α-ASK1-JNK1通路关键蛋白(P-IRE1α、P-ASK1、P-JNK1、P-c-Jun)表达水平。结果 RJE可改善NASH小鼠肝脏脂肪变性、减轻炎症和纤维化程度,降低血清ALT、AST水平以及肝组织炎症和纤维化标志物表达(P<0.05);AML-12中,RJE提高细胞存活率,下调炎症因子mRNA表达,并抑制IRE1α-TRAF2-ASK1-JNK1通路活化(P<0.05)。结论 RJE通过抑制AML-12细胞中IRE1α-TRAF2-ASK1-JNK1通路的过度激活,降低内质网应激,减轻肝细胞异常凋亡损伤和炎症反应,从而缓解NASH病理进展。
关键词:  蓝萼香茶菜  非酒精性脂肪性肝炎  内质网应激  细胞凋亡
DOI:10.13506/j.cnki.jpr.2026.01.001
基金项目:国家自然科学基金项目(No.82170877)
出版日期:2026-01-26
Rabdosia japonica extract alleviate non-alcoholic steatohepatitis in mice by inhibiting the IRE1α-TRAF2-ASK1-JNK1 pathway
ZHANG Yifan,HU Xinyi,SHENG Liang
(Nanjing Medical University,Nanjing 211166,China)
Abstract:
Objective To investigate the therapeutic effects and mechanisms of Rabdosia japonica extract (RJE) on non-alcoholic steatohepatitis (NASH).Methods NASH was induced in C57BL/6 mice using a choline-deficient, L-amino acid-defined high-fat diet (CDAHFD). The mice were treated with RJE (0.2 and 0.4 mL•10 g-1) for 2 weeks. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured. Liver pathology was assessed by hematoxylin-eosin (H&E), Oil Red O, and Sirius Red staining. Hepatic triglyceride (TAG) and hydroxyproline levels were quantitatively analyzed. RT-qPCR was used to measure mRNA expression of liver tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), monocyte chemoattractant protein-1 (MCP-1), C-C motif chemokine ligand 5 (CCL5), transforming growth factor-β (TGF-β), α-smooth muscle actin (α-SMA), and collagen type I alpha 1 (Collagen1a1). Western blotting was performed to analyze α-SMA protein expression. Potential therapeutic targets of RJE were predicted by intersecting RJE-related targets from network databases with NASH-related targets, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. For in vitro experiments, AML-12 cells were treated with palmitic acid (PA, 0.33 mmol•L-1) and lipopolysaccharide (LPS, 1 μg•mL-1) to establish an NASH model. After RJE (5 μg•mL-1) intervention for 20 h, cell viability was assessed, and RT-qPCR was used to analyze inflammatory factor expression (TNF-α,IL-1β,MCP-1,CCL5). Western blotting was performed to detect key proteins in the IRE1α-ASK1-JNK1 pathway (P-IRE1α, P-ASK1, P-JNK1, P-c-Jun).Results RJE significantly ameliorated hepatic steatosis, inflammation, and fibrosis in NASH mice, reduced serum ALT and AST levels, and downregulated the expression of hepatic inflammatory and fibrotic markers (P<0.05). In AML-12 cells, RJE improved cell viability, suppressed inflammatory cytokine mRNA expression, and inhibited the activation of the IRE1α-TRAF2-ASK1-JNK1 pathway (P<0.05). Conclusion RJE alleviates NASH progression by inhibiting the hyperactivation of the IRE1α-TRAF2-ASK1-JNK1 pathway in AML-12 cells, reducing endoplasmic reticulum stress, attenuating hepatocyte apoptosis, and mitigating inflammatory responses.
Key words:  Rabdosia japonica  Non-alcoholic steatohepatitis  Endoplasmic reticulum stress  Apoptosis
今日访问量:2274    总访问量:55338616
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司